Peptide record

TPDB27847

Exendin-4 Blood-Brain Barrier Toxicity standard
39 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB27847
Exendin-4
Blood-Brain Barrier Toxicity
Toxicity and safety peptides Delivery and barrier-penetrating peptides
BBPpredict Peptipedia pep-lab PEPlife
standard
No
A 39-aa standard-residue multi-activity (Blood-Brain Barrier and Toxicity) peptide sequence curated from BBPpredict, Peptipedia, pep-lab, and other sources, with an available 3D structural model.
Sequence
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C184H281N49O61S1
CY
EGS
4187.61
4.49
4
6
11
-3
1.67
-0.692
52.56
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
5500
1.31
9
Residue Composition
number
2
A
1
R
1
N
1
D
0
C
5
E
1
Q
5
G
1
H
1
I
3
L
2
K
1
M
2
F
4
P
5
S
2
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 1 N: 1 D: 1 C: 0 E: 5 Q: 1 G: 5 H: 1 I: 1 L: 3 K: 2 M: 1 F: 2 P: 4 S: 5 T: 2 W: 1 Y: 0 V: 1
Chemical Descriptors
39 reviewed residue count
C184H281N49O61S1 sequence-only estimate (linear, free termini)
4187.61 sequence-only estimate (linear, free termini)
4.49 sequence-only estimate (linear, free termini)
-3 sequence-only estimate (linear, free termini)
1.67 sequence-only estimate (linear, free termini)
-0.692 sequence-only estimate (linear, free termini)
Linear Activity
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser Activity
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N Activity
Evidence Records 12 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.0004621 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Intravenous
Saturable
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.047 min-1

Assay & Model

Efflux study ICU
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Permeability
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
14.6 min

Assay & Model

Efflux study ICU
half life, brain

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Permeability
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
0.01895 mL/(g x min)

Assay & Model

Unidirectional flux rate constant

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
in situ brain perfusion
Saturable
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.0156 ml/g

Assay & Model

Capillary depletion
Capillary depletion (parenchyma/serum)

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
0.0029 ml/g

Assay & Model

Capillary depletion
Capillary depletion (parenchyma/serum)

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 7 Activity

Activity

Blood-Brain Barrier
84%

Assay & Model

Capillary depletion
% parenchyma

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 8 Activity

Activity

Blood-Brain Barrier
16%

Assay & Model

Capillary depletion
% capillary

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 9 Activity

Activity

Blood-Brain Barrier
0.0178 ml/g

Assay & Model

Capillary depletion
Capillary depletion (brain/serum)

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 10 Activity

Activity

Blood-Brain Barrier
82.8 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 11 Activity

Activity

Blood-Brain Barrier
60 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Evidence 12 Activity

Activity

Blood-Brain Barrier
0.099

Assay & Model

Shake Flask
Log D

Source & Reference

NA
B3Pdb

Other

human,bovine,mouse,rat,porcine
Direct iodination
Additional Detail Fields 8 fields
Radioimmunoassay
in vitro
8640.0
hours
N.A.
Intravenous in situ brain perfusion
4186.6
N.A.